Supply treatment courses for the U.S. Strategic National Stockpile

Deadline not yet reached (796 days left)

Announced: 13 Oct 2023
Due: 31 Dec 2028

Deadline
Met
Late
Not met
Today

What the company said

“Pfizer will manage and supply 1.0 million treatment course U.S. Strategic National Stockpile (SNS) to enable future pandemic preparedness and refresh stock prior to expiry through 2028.”

SourcePfizer Inc. Form 8-K press release, 2023-10-13
FilingSEC filing index
Deadline as statedthrough 2028
Deadline used31 Dec 2028, the last day of the stated period
TypeProduct
Permanent referenceKI-C-2023-PFE-004741
Cite as https://keptindex.org/c/KI-C-2023-PFE-004741/ — this address never changes.

What we found

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 31 Dec 2028.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type: Product other
Indicative materiality: Low rules
Action: Supply
Deliverable: 1.0 million treatment courses for Strategic National Stockpile
Target: 1 million treatment courses
Where: U.S.
Language: Firm (“will”, “on track to”)
In the company’s control: High
Specificity: High
Depends on: Customer

Tell me what happens

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Alert me when this resolves

How this entry was checked

Commitment recordedThe company's words were matched word for word against the filing.
OutcomeNot yet assessed. Nothing is judged before the deadline.

Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2023-PFE-004741 · Corrections policy